CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Philippines

2019-11-29
Price :
Published : Nov-2019
No. of Pages : 144

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Philippines

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Philippines”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Philippines healthcare market is one of the major emerging markets in the world, with a strong focus on research and development (R&D). The Philippines pharmaceutical market increased from ?128B in 2011 to ?176B in 2018 at a Compound Annual Growth Rate (CAGR) of 4.65%. In terms of US dollars, the pharmaceutical market was $2.96B in 2011, which increased to $3.34B in 2018 at a CAGR of 1.75%. The Philippines medical device market was valued at $196.18M in 2015, which increased to $227.10M in 2018. The Philippines pharmaceutical and medical device market is import-driven.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, and includes –
– An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical market (Unilab, Pfizer, GSK, Boehringer and Sanofi) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Fresenius Medical Care, Siemens Healthineers, and Philips Healthcare.)
– Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Philippines
– Porter’s five forces analysis for pharmaceutical and medical devices market of Philippines
– An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
– Information regarding the health-tech landscape of the country along with the major health-tech deals
– Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
– An overview of the opportunities and challenges to growth in the Philippines healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:
– Develop business strategies by understanding the trends shaping and driving the Philippines healthcare market
– Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
– Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
– Identify, understand, and capitalize on the opportunities and challenges in the Philippines healthcare market

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Women’s Health Care Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) – Global forecast to 2024

“Growing incidence of chronic health conditions among women and the demand in contraceptives to prevent unintended pregnancies are the key factors driving the women’s healthcare market.” The global women’s healthcare market is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period. Growth in this market is mainly driven by the growing incidence of chronic health conditions among women, growing demand for contraceptives to prevent unintended pregnancies, growing focus on R&D by key players for the development of advanced products, and the government initiatives to curb population growth. On the other hand, the reluctance to use contraceptives is a major factor limiting the market growth. “Prolia is the larg......
$5650

Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024

“The stable isotope labeled compounds market is projected to grow at a CAGR of 3.0% during the forecast period (2019–2024).” The global stable isotope labeled compounds market size is projected to reach USD 312 million by 2024 from USD 269 million in 2019, at a CAGR of 3.0%. The growth of this market is driven majorly by factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. However, the high cost of stable isotope-labeled compounds is expected to restrain the growth of this market during the forecast period. “By type, the H-2 labeled compounds segment is expected to grow at the highest CAGR during the forecast period.” Based on component, the stable isotope-labe......
$5650

North American Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, PHM CRM, RCM, Telehealth, Healthcare Analytics, Supply Chain Management, mHealth, Fraud Analytics, Medication & Claims Management) End User (Provider,Payer) – Forecast to 2025

“North America healthcare IT market size to grow at a 16.4% CAGR” The North America healthcare IT market size is projected to reach USD 239.9 billion by 2025 from USD 96.3 billion in 2019, at a CAGR of 16.4%. There is a growing inclination across the globe towards the adoption of healthcare technologies due to the increasing need to deliver quality care to patients while curtailing escalating costs. These robust IT solutions are designed to streamline workflow in healthcare systems, reduce expenses, and facilitate compliance with stringent regulatory guidelines. “Based on products and services, the healthcare providers segment accounted for the largest share of the North America Healthcare IT market in 2018” Based on products and services, the market is segmented into heal......
$6150

Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028

Seasonal Influenza: Epidemiology Forecast in Asia-Pacific Markets to 2028 Summary Seasonal influenza is a contagious respiratory viral illness. There are four types of seasonal influenza viruses (A, B, C, and D); however, only types A and B cause human disease of public health concern. Influenza transmission occurs when people with flu cough, sneeze, or talk and disseminate droplets. These droplets can land in the mouths or noses of people who then inhale them into the lungs. GlobalData epidemiologists identified country-specific population-based studies published in peer-reviewed journal articles and government-collated surveillance data to build the influenza forecast, and utilized appropriate proxy data where applicable. In 2018, there were 18,518,017 cases of lab-confirmed seasonal ......
$3495

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Colombia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Colombia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Colombia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and i......
$1995

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Malaysia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Malaysia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house ......
$1995

Multiple Sclerosis – Global Drug Forecast and Market Analysis to 2028

Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2028 Summary MS is a primary autoimmune disease with a mechanism involving recurrent inflammatory attacks on the central nervous system (CNS) due to a dysfunctional immune system, leading to neurological disability . The exact underlying cause of the inflammatory autoimmune process remains unknown; however, it is widely believed that MS results from a complex interaction of genetic susceptibility and environmental factors. MS is primarily considered an inflammatory demyelinating disorder of the CNS, and is characterized by lymphocyte and macrophage infiltrates, as well as glial cell activation. The key pathological finding in MS neural tissue is the presence of diffuse inflammatory lesions, also known as plaques, which are......
$10995

Generalized Seizures Global Clinical Trials Review, H2, 2019

Generalized Seizures Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, "Generalized Seizures Global Clinical Trials Review, H2, 2019" provides an overview of Generalized Seizures clinical trials scenario. This report provides top line data relating to the clinical trials on Generalized Seizures . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clini......
$2500

Myocardial Ischemia Global Clinical Trials Review, H2, 2019

Myocardial Ischemia Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, "Myocardial Ischemia Global Clinical Trials Review, H2, 2019" provides an overview of Myocardial Ischemia clinical trials scenario. This report provides top line data relating to the clinical trials on Myocardial Ischemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical t......
$2500

Treatment Resistant Depression Global Clinical Trials Review, H2, 2019

Treatment Resistant Depression Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, "Treatment Resistant Depression Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Resistant Depression clinical trials scenario. This report provides top line data relating to the clinical trials on Treatment Resistant Depression. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's pro......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy